Augmedix
(NASDAQ) AUGX
This security has been delisted. This page is retained for historical reference.
AUGX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAUGX Financials
Key Financial Metrics (TTM)
Gross Margin
47.99%
Operating Margin
-41.87%
Net Income Margin
-42.74%
Return on Equity
-154.69%
Return on Capital
-37.07%
Return on Assets
-28.74%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$24.87M
Operating Income
-$23.88M
EBITDA
-$19.62M
Operating Cash Flow
-$15.39M
Capital Expenditure
-$2.56M
Free Cash Flow
-$17.95M
Cash & ST Invst.
$28.22M
Total Debt
$26.71M
Augmedix Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$13.66M
+26.8%
Gross Profit
$6.46M
+27.4%
Gross Margin
47.24%
N/A
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
N/A
N/A
Employees
1,430
N/A
Net Income
-$8.45M
-67.9%
EBITDA
-$7.31M
-75.6%
Quarterly Fundamentals
Total Cash
$28.22M
+11.7%
Total Debt
$26.71M
+34.0%
Accounts Receivable
$9.25M
-1.9%
Inventory
$0.00
+100.0%
Long Term Debt
$18.84M
+8.5%
Short Term Debt
$7.86M
-1.0%
Return on Assets
-28.74%
N/A
Return on Invested Capital
-43.58%
N/A
Free Cash Flow
-$4.25M
+41.4%
Operating Cash Flow
-$3.89M
+34.7%